-
Product Insights
Likelihood of Approval Analysis for Ocular Inflammation
Overview How likely is it that the drugs in Ocular Inflammation will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ocular Inflammation Overview Ocular inflammation is an eye inflammation that include choroiditis,...
-
Product Insights
Likelihood of Approval Analysis for Pyelonephritis
Overview How likely is it that the drugs in Pyelonephritis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pyelonephritis Overview Pyelonephritis is a specific type of urinary tract infection (UTI) that...
-
Product Insights
Likelihood of Approval Analysis for Salmonella Infections
Overview How likely is it that the drugs in Salmonella Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Salmonella Infections Overview Salmonellosis is a symptomatic infection caused by bacteria of...
-
Product Insights
Likelihood of Approval Analysis for Tetanus
Overview How likely is it that the drugs in Tetanus will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tetanus Overview Tetanus is a serious illness caused by Clostridium bacteria. Signs and...
-
Product Insights
Likelihood of Approval Analysis for Hospital Acquired Pneumonia (HAP)
Overview How likely is it that the drugs in Hospital Acquired Pneumonia (HAP) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hospital Acquired Pneumonia (HAP) Overview Hospital-acquired pneumonia (HAP) is defined...
-
Product Insights
Likelihood of Approval Analysis for Influenza A Virus, H3N2 Subtype Infections
Overview How likely is it that the drugs in Influenza A Virus, H3N2 Subtype Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Influenza A Virus, H3N2 Subtype Infections Overview H3N2...
-
Product Insights
Likelihood of Approval Analysis for Community Acquired Pneumonia
Overview How likely is it that the drugs in Community Acquired Pneumonia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Community Acquired Pneumonia Overview Community-acquired pneumonia (CAP) is defined as pneumonia...
-
Product Insights
Likelihood of Approval Analysis for Acne Vulgaris
Overview How likely is it that the drugs in Acne Vulgaris will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acne Vulgaris Overview Acne vulgaris is a chronic skin disease involving blockage...
-
Product Insights
Likelihood of Approval Analysis for Rosacea
Overview How likely is it that the drugs in Rosacea will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rosacea Overview Rosacea is a chronic and potentially life-disruptive disorder primarily of the...
-
Product Insights
Likelihood of Approval Analysis for Irritable Bowel Syndrome
Overview How likely is it that the drugs in Irritable Bowel Syndrome will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Irritable Bowel Syndrome Overview Irritable bowel syndrome (IBS) is a functional...